| 11208495 |
Anti-TM4SF1 antibodies and methods of using same |
Paul A. Jaminet, Shou-Ching S. Jaminet, Harold F. Dvorak |
2021-12-28 |
| 11174306 |
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
Travis Young, David Rodgers, Eric HAMPTON, Timothy WRIGHT, Peter G. Schultz +3 more |
2021-11-16 |
| 11161915 |
Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof |
Dunja Urosev, Stacey A. L. Tom-Yew, Mario Sanches |
2021-11-02 |
| 11147886 |
Drug-conjugated bi-specific antigen-binding constructs |
Gordon Yiu Kon Ng, Thomas Spreter Von Kreudenstein |
2021-10-19 |
| 11091546 |
Optimized PNE-based chimeric receptor T cell switches and uses thereof |
Travis Young, David Rodgers, Ian Hardy, Chanhyuk Kim, Peter G. Schultz +2 more |
2021-08-17 |
| 11072662 |
Humanized anti-CLL-1 antibodies |
Ying-Ping Jiang, Jagath Reddy Junutula, Naoya Tsurushita |
2021-07-27 |
| 11028182 |
Antigen-binding constructs targeting HER2 |
Eric Escobar-Cabrera |
2021-06-08 |
| 10975147 |
Modified J-chain |
Bruce Keyt, Fen Zhang, Ramesh Baliga |
2021-04-13 |
| 10954302 |
Anti-PD-L1 antibodies |
Bruce Keyt, Ramesh Baliga |
2021-03-23 |
| 10927172 |
Caninized murine antibodies to human PD-1 |
Mohamad Morsey, Yuanzheng Zhang, Denise Bartels-Morozov, Jason Erskine, Ian Tarpey |
2021-02-23 |